Synthesis, in vitro anti-HIV activity, and biological stability of 5'- O-myristoyl analogue derivatives of 3'-fluoro-2',3'dideoxythymidine (FLT) as potential bifunctional prodrugs of FLT

Nucleosides and Nucleotides

Volumn 17, Issue 6, 1998, Pages 987-1008

  Parang, Keykavous ^a   Knaus, Edward E ^a   Wiebe, Leonard I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUORO 2',3' DIDEOXY 5' O (12 AZIDODODECANOYL)THYMIDINE; 3' FLUORO 2',3' DIDEOXY 5' O (12 METHOXYDODECANOYL)THYMIDINE; 3' FLUOROTHYMIDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; LAMIVUDINE; PRODRUG; STAVUDINE; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SUIDAE;

EID: 0031750052     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319808004216     Document Type: Article

References (40)

1. Coates, J. A.; Commack, N.; Jenkinson, H. J.; Mutton, I. M.; Pearson, B. A.; Storer, R.; Cameron, J. M.; Penn, C. R. Antimicrob. Agents Chemother., 1992, 36, 202-205.
2. Mitsuya, H.; Broder, S. Proc. Natl. Acad. Sci. USA, 1986, 6, 1911-1959.
3. Mitsuya, H.; Weinhold, K. J.; Furman, P. A.; St. Clair, M. H.; Lehrman, S. N.; Gallo, R. C.; Bolognesi, D.; Barry, D. W.; Broder, S. Proc. Natl. Acad. Sci. USA, 1985, 82, 7096-7100.
4. Balzarini, J., G.; Kang, J.; Dalal, M.; Herdewijn, P.; De Clercq, E.; Broder, S.; Johns, D. G. Mol. Pharmacol., 1987, 32, 162-170.
5. Yarchoan, R.; Mitsuya, H.; Thomas, R. V.; Pluda, J. M.; Hartman, N. R.; Perno, C. F.; Marczyk, K. S.; Allain, J. P.; Johns, D. G.; Broder, S. Science, 1989, 245, 412- 415.
6. Balzarini, J.; Baba, M.; Pauwels, R.; Herdewijn, P.; De Clercq, E. Biochem. Pharmacol., 1988, 37, 2847-2856.
7. Kong, X.-B.; Zhu, Q.-Y.; Vidal, P.M.; Watanabe, K. A.; Polsky, B.; Armstrong, D.; Ostrander, M.; Lang, S. A. Jr.; Muchmore, E.; Chou, T.-C. Antimicrob. Agents Chemother., 1992, 36, 808-818.
8. Matthes, E.; Lehnmann, C. M.; Scholz, D.; Rosenthal, H. A.; Langen, P. Biochem. Biophys. Res. Commun., 1988, 153, 825-831.
9. Hiebl, J.; Zbiral, E.; von Janta-Lipinski, M. V.; Balzarini, J.; De Clercq, E. Antiviral Chem. Chemother., 1996, 7, 173-177.
10. Sandström, E.; Öberg, B. Drugs, 1993, 45, 488-508.
11. Schinazi, R. F.; Mead, J. R.; Feorino, P. M. AIDS Res. Hum. Retroviruses, 1992, 8, 963-978.
12. Harmenberg. J.; Akesson-Johansson, A.; Vreng, L.; Cox, S. AIDS Res. Hum. Retroviruses, 1990, 6, 1197-1202.
13. Gosselin, G.; Périgaud, C.; Lefebvre, I.; Pompou, A.; Aubertin, A. M.; Kern., A.; Szabo, T.; Stawinski, J.; Imbach, J. L. Antiviral Res., 1993, 22, 143-153.
14. McGuigan, C.; Jones, B. C. N. M.; Devine, K. G.; Nicholls, S. R.; O'Conner, T. J.; Kinchington, D. Bioorg. Med. Chem. Lett., 1991, 1, 729-732.
15. Rahim, S. G.; Bogunovic-Batchelor, M. V.; Tranter, G. E. European Patent, 1991, 442,757 A2; Chem. Abst., 115:183813c.
16. Rahim, S. G.; Bogunovic-Batchelor, M. V.; Tranter, G. E. European Patent, 1991, 442,757 A2; Chem. Abst., 115:183813c.
17. Kumar, R.; Wang, L.; Wiebe, L. I.; Knaus, E. E. J. Med. Chem., 1994, 37, 3554-3560.
18. Aggarwal, S. K.; Gogu, S. R.; Rangan, S. R. S.; Agrawal, K. C. J. Med. Chem., 1990, 33, 1505-1510.
19. Torrence, P. F.; Kinjo, J.; Khamnei, S.; Greig, N. H. J. Med. Chem., 1993, 36, 529- 537.
20. Kawaguchi, T.; Ishikawa, K.; Seki, T.; Juni, K. J. Pharm. Sci., 1990, 79, 531-533.
21. Palomino, E.; Kessel, D.; Horwitz, J. P. J. Med. Chem., 1989, 32, 622-625.
22. Chu, C. K.; Bhadti, V. S.; Doshi, K. J.; Etse, E. T.; Gallo, J. M.; Boudinot, F. D.; Schinazi, R. F. J. Med. Chem., 1990, 33, 2188-2192.
23. Paige, L. A.; Zheng, G.; Shawn, A. D.; Cassady, J. M.; Geahlen, R. L. Biochem., 1990, 29, 10566-10573.
24. Schultz, A. M.; Oroszlan, S. J. Virol., 1983, 46, 355-361.
25. Langner, C. A.; Travis, J. K.; Caldwell, S. J.; Tianbao, J. E.; Li, Q., Bryant, M. L.; Devadas, B.; Gokel, G. W.; Kobayashi, G. S.; Gordon, J. I. J. Biol. Chem., 1992, 267, 17159-17169.
26. Parang, K.; Wiebe, L. I.; Knaus, E. E.; Huang, J.-S.; Tyrrell, D. L.; Csizmadia, F. Antiviral Res., 1997, 34, 75-90.
27. Gordon, J. I.; Adams, S. P.; Heuckeroth, R. O. European. Patent., 1991, 0,415,902 A1; Chem. Abstr., 115:774y.
28. Gordon, J. I.; Adams, S. P.; Heuckeroth, R. O. European. Patent., 1991, 0,415,902 A1; Chem. Abstr., 115:774y.
29. Nugent, S. T.; Mueller, R. A. US Patent, 1997, 5,599,947; Chem. Abst., 126:199830.
30. Nugent, S. T.; Mueller, R. A. US Patent, 1997, 5,599,947; Chem. Abst., 126:199830.
31. Adams, S. P.; Devadas, B.; Gordon, J. I. European Patent., 1992, 0 480 901 A1; Chem. Abstr., 117:89841e.
32. Adams, S. P.; Devadas, B.; Gordon, J. I. European Patent., 1992, 0 480 901 A1; Chem. Abstr., 117:89841e.
33. Herdewijn, P.; Balzarini, J.; De Clercq, E.; Pauwels, R.; Baba, M.; Broder, S.; Vanderhaeghe, H. J. Med. Chem., 1987, 30, 1270-1278.
34. Parang, K.; Wiebe, L. I; Knaus, E. E. Antiviral. Chem. Chemother., 1997, 8, 417-427.
35. Balzarini, J.; Cools, M.; De Clercq, E. Biochem. Biophys. Res. Commun., 1989, 158, 413-422.
36. Hansch, C.; Fujita, T. J. Am. Chem. Soc., 1964, 86, 1616-1626.
37. Silverman, R. B. In: The organic chemistry of drug design and drug action, Academic Press, Inc. 1992, 352-327.
38. Czernecki, S.; Valery, J.-M. Synthesis, 1991, 239-240.
39. Weislow, O. W.; Kiser, R.; Fine, D.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. J. Natl. Cancer Inst., 1989, 81, 577-586.
40. Tandon, M.; Singh, S.; Xu, L.; Kumar, P.; Wiebe, L. I.; Knaus, E. E.; Gati, W. P.; Tempest, M. L. Drug Des. Dis., 1992, 9, 79-91.